Status: Recruiting
Stem Cell Ophthalmology Treatment Study II
This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease.
Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: MD Stem CellsUpdated: Jun 29, 2026Locations: 4
Eligibility criteria
Have objective, documented damage to the retina or optic nerve unlikely to impro... [+7]
Patients who are not capable of an adequate ophthalmologic examination or evalua... [+3]